ANDITM featured in new publication
An independent scientific article about ANDI has been published in BMC Neurology by Dr. Cyrus Raji, from the Washington School of Medicine, and his team.
ImekaTM lets you see white matter like you’ve never seen it before
Go from raw data to a comprehensive report with ANDI. Our proprietary, fully automated, and validated quantitative clinical software performs all the steps required to create a streamlined and clinically relevant report for radiologists and neurologists.
Book a demo
Our validated clinical software is backed by years of R&D with the world’s top pharmaceutical companies and MRI manufacturers. We are committed to continuing the development of ANDI and validating novel biomarkers that will push our clinical tool further.
Neuroinflammation. Axonal integrity. Myelin integrity. White matter health. We see all that and more—at a level of detail that is unmatched in the industry. Rely on our expertise in Traumatic Brain Injury, Alzheimer’s disease, Multiple Sclerosis, and other white matter pathologies.
About ImekaTM
An independent scientific article about ANDI has been published in BMC Neurology by Dr. Cyrus Raji, from the Washington School of Medicine, and his team.
You can meet us at RSNA in Chicago December 1st – 5th, 2024 to discuss quantitative MRI and introduce ANDI to Neuroradiologists and corresponding enthusiasts.